These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17241851)
1. Combination therapy with telaprevir and pegylated interferon suppresses both wild-type and resistant hepatitis C virus. Lang L Gastroenterology; 2007 Jan; 132(1):5-6. PubMed ID: 17241851 [No Abstract] [Full Text] [Related]
2. Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Kieffer TL; Sarrazin C; Miller JS; Welker MW; Forestier N; Reesink HW; Kwong AD; Zeuzem S Hepatology; 2007 Sep; 46(3):631-9. PubMed ID: 17680654 [TBL] [Abstract][Full Text] [Related]
3. Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Pawlotsky JM Hepatology; 2011 May; 53(5):1742-51. PubMed ID: 21374691 [TBL] [Abstract][Full Text] [Related]
4. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye. Dusheiko G; Wedemeyer H Gut; 2012 Dec; 61(12):1647-52. PubMed ID: 22936671 [No Abstract] [Full Text] [Related]
5. Peginterferon and ribavirin for chronic hepatitis C. Hoofnagle JH; Seeff LB N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366 [No Abstract] [Full Text] [Related]
6. [Treatment of hepatitis C infection: towards eradication of chronic virus]. Ahola T; Kaukinen P Duodecim; 2012; 128(18):1911-7. PubMed ID: 23088003 [TBL] [Abstract][Full Text] [Related]
7. The changing therapeutic landscape for hepatitis C. Dore GJ Med J Aust; 2012 Jun; 196(10):629-32. PubMed ID: 22676877 [TBL] [Abstract][Full Text] [Related]
8. Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF). ; Coco B; Caraceni P; Aghemo A; Bitetto D; Bruno R; Ciancio A; Marzioni M; Petta S; Rendina M; Valenti L; Dig Liver Dis; 2014 Jan; 46(1):18-24. PubMed ID: 24119482 [TBL] [Abstract][Full Text] [Related]
13. Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough. Shiffman ML; Rustgi VK Gastroenterology; 2006 Oct; 131(4):1339-41. PubMed ID: 17030201 [No Abstract] [Full Text] [Related]
14. Treating hepatitis C: are children the same as adults? Delgado-Borrego A Gastroenterology; 2011 Feb; 140(2):389-92. PubMed ID: 21172331 [No Abstract] [Full Text] [Related]
15. Peginterferon and ribavirin for hepatitis C. Abramowicz M N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100 [No Abstract] [Full Text] [Related]
16. ADVANCE study begins enrollment. AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463 [No Abstract] [Full Text] [Related]
18. [Treatment for chronic hepatitis C, more opportunity, more challenge]. Wei L Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676 [No Abstract] [Full Text] [Related]
19. Hepatitis C virus therapy to date. Foster G; Mathurin P Antivir Ther; 2008; 13 Suppl 1():3-8. PubMed ID: 18432157 [TBL] [Abstract][Full Text] [Related]
20. [Recent developments in the treatment of chronic hepatitis B and C]. Chamuleau RA Ned Tijdschr Tandheelkd; 2007 Aug; 114(8):353-6. PubMed ID: 17822245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]